174) Compared to controls at this stage, exposu |
175) s of animals exposed to d-phenothrin when compared to controls. |
176) of wound contraction and reepithelisation compared to controls. |
177) luteinising hormone (LH) in HCD group as compared to controls. |
178) voxel-wise morphometry in PG subjects as compared to controls. |
179) D was reduced in CHD patients (P<0.05) compared to controls. |
180) novel learning of spatial configurations compared to controls. |
181) wer at each sampling time post-activation compared to controls. |
182) re highly expressed in hemangioma samples compared to controls. |
183) ntents at various stages of wound healing compared to controls. |
184) re were more likely to be innovators when compared to other centrally-located PCAs, |
185) a lower rate of graft versus host disease compared to other donor sources. |
186) he weakest intentions to report rape when compared to other ethnic groups, cultural |
187) elevated risk for depression and suicide compared to other ethnic groups. |
188) splatin-loaded targeted-nanogel treatment compared to other formulations. |
189) decreased significantly in the SFNC group compared to other groups (p<0.05). |
190) ontrolled statistically when the IPDS was compared to other measures of psychopathol |
191) berculosis infection (LTBI) treatment, as compared to other referral groups, and to |
192) (0.02) and it was very low (0.011), when compared to other species of Gallus. |
193) ad significantly lower risk-adjusted rate compared to other surgical inpatients for |
194) in patients with systemic sclerosis (SSc) compared to healthy controls by measuring |
195) te normal mimicry in children with ASD as compared to healthy controls, but that in |
196) intervals, starting at the diagnosis, and compared to healthy controls. |
197) ference has been evidenced in AS patients compared to healthy controls. |
198) sture, in patients with Meniere's disease compared to healthy general population. |
199) O, P < 0.0001) in AWD/CDH infants compared to healthy infants at birth but h |
200) atic body areas differ in EDS-HT patients compared to healthy subjects. |
201) hreshold in a group of rheumatic patients compared to healthy subjects. |
202) antly reduced inspiratory muscle strength compared to healthy term born infants but |
203) Compared to their counterparts who did not |
204) The predicted models were compared to their CT joint models. |
205) tions in African Americans with NSCLC, as compared to their White counterparts. |
206) 6 h produced maximum inhibition of CFU compared to their controls for both microo |
|